Isotechnika Pharma Inc IPHAF

RE: Price target - oldtimer

[stockman6]

I wouldn't put too much stock in weepee's assessment. 1. A quick look at what he's investing in will tell you he doesn't believe it, or follow the approach himself (i.e. RRL, NEM, etc.). You will find in time that his "approach" correlates closely to whether he is short or long on the stock. 2. As I posted a couple weeks ago, the biotech industry is not a place to look for "value" stocks. If you do a little research you can find companies trading below book value; below cash on hand for that matter. If you want to follow Teevee's model and invest in these "under valued" stocks, go ahead, but they are invariably those who's drug trials have shown poor results. Biotech investing has always been speculative in nature, based on potential, and should be treated as such. But to value ISA at cash on hand puts no value on the successful trials done to-date, the time and money spent to get the drug to this point, and the $2Billion+ potential market cap.